Archive for Urology News



Page 11234..1020..»


Anavo Therapeutics Launches with EUR 20 Million Seed Financing to Create Industry-Leading Pipeline of Allosteric Phosphatase Modulators – Business…

LEIDEN, The Netherlands--(BUSINESS WIRE)--Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of human phosphatase biology, debuted today with a EUR 20 million (approx. $24 million) seed financing.

Read More..

Adding a First-Generation Anti-Androgen to ADT for mCSPC Does Not Improve Outcomes – Renal and Urology News

Adding an anti-androgen such as bicalutamide or flutamide to androgen deprivation therapy (ADT) for metastatic castration-sensitive prostate cancer (mCSPC) does not improve outcomes compared with ADT alone, according to an analysis of real-world evidence presented at the virtual 2021 Genitourinary Cancers Symposium. In a retrospective study of data from the Veterans Health Administration database, a team led by Stephen J. Freedland, MD, of Cedars-Sinai Medical Center in Los Angeles, California, and the Durham VA Medical Center in Durham, North Carolina, found that ADT plus an anti-androgen and ADT alone were associated with a similar time to development of castration-resistant disease (21.4 vs 22.5 months).

Read More..

UW chemist and oceanographer named Sloan Fellows – UW News

News releases February 16, 2021 Two faculty members at the University of Washington have been awarded early-career fellowships from the Alfred P.

Read More..

Valentine’s Day Getting You Down? Erectile dysfunction might not just be affecting your relationship, it could be a sign of something deadly -…

Erectile dysfunction can be an important cardiovascular disease risk factor like smoking or family history. Because the penile arteries are smaller than the cardiac arteries, plaque formation will preferentially show up first as ED.

Read More..

Corbin Clinical Resources, Inc. Welcomes New Executive Team – PRNewswire

CUMBERLAND, Md., Feb. 16, 2021 /PRNewswire/ --Corbin Clinical Resources, parent company of Perineologic, is a privately held medical device manufacturer

Read More..

Creative Medical Technology Holdings Files Patent on Prevention of Organ Transplant Rejection using ImmCelz – PRNewswire

PHOENIX, Feb.

Read More..

Metro Health opens vaccine site that will focus on underserved populations – WZZM13.com

The Community Clinic, located on 36th Street SE, near Eastern Avenue, is Metro Health's first vaccine distribution site outside the main hospital. GRAND RAPIDS, Mich. Metro Health - University of Michigan has opened a new COVID-19 vaccination clinic in Grand Rapids that will focus on underserved populations

Read More..

Florida Healthcare Specialists Offering Innovative Procedure to Treat Symptoms of Enlarged Prostate – GlobeNewswire

Urologist Hugo Davila, MD Fort Myers, Fla., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Florida Healthcare Specialists (FHS), a clinical practice of Florida Cancer Specialists (FCS), has added an innovative new treatment option that provides lasting relief for men experiencing symptoms of benign prostatic hyperplasia (BPH), also known as an enlarged prostate. Rezm Water Vapor Therapy uses natural water vapor to reduce the size of the prostate and provide lasting symptom relief without invasive surgery or the potential side effects of prescription drugs.

Read More..

Black History Month: Monumental moments at the WSU School of Medicine – The South End

Jaila Campbell, seen here as part of the Warrior Strong campaign, is a Wayne State University medical student and a graduate of the Post-Baccalaureate Program.

Read More..

Treating Men With Overactive Bladder Nonresponsive to Antimuscarinics – Renal and Urology News

The beta-3 agonist mirabegron has the most evidence for treating overactive bladder (OAB) in men after inefficacy or intolerability of antimuscarinic therapy at 8 to 12 weeks, according to the authors of a new systematic review published in European Urology. But more research on treatment options for men is clearly needed. Cosimo De Nunzio, MD, PhD, of Sapienza, University of Rome in Rome, Italy, and colleagues conducted a review of 24 studies focusing on male patients with OAB.

Read More..

Same-Day Robotic Urologic Surgery During the COVID-19 Crisis Not Riskier – Renal and Urology News

Investigators who studied the effect of the COVID-19 pandemic on same-day discharge (SDD) of patients following robotic urologic surgery found no increase in 30-day complication and readmission rates compared with before the pandemic, according to a recent report. During crises like the COVID-19 pandemic, adopting a protocol of SDD after robotic surgery may allow more surgeries to be performed while preserving hospital beds and reducing postoperative patient exposure to infection and may allow for cost savings in the absence of such a crisis, Ronney Abaza, MD, of OhioHealth Robotic Urologic and Cancer Surgery in Dublin, Ohio, and colleagues concluded in a paper published online in Urology. The investigators conducted a single-institution study that compared 89 robotic urologic surgeries performed from March 17 to June 5, 2020 (defined as the COV period) with 1667 historical controls who had the same procedures performed prior to the pandemic (pre-COV group).

Read More..

Verana strikes research collaboration with Janssen on ophthalmology and urology – MedCity News

Healthcare analytics startup Verana Health struck a partnership with a subsidiary of Johnson & Johnson. The company will work with Janssen Research and Development in a research collaboration development focused on ophthalmology and urology. San Francisco-based Verana originally started as a tele-ophthalmology startup, but pivoted two years ago to make tools for physicians and researchers using de-identified data from patient registries.

Read More..

Women, critical care physicians report highest level of burnout – Healthcare IT News

Critical care physicians report the highest level of burnout, with bureaucratic tasks and long work hours contributing to feelings of dread, discouragement and anxiety, finds a new report from Medscape. In a survey of more than 12,000 physicians across 29 specialties conducted between August 30 and November 5, 2020, providers noted that the stress of treating COVID-19 patients did not substantially increase burnout - although it did exacerbate existing issues. Only about half of the physicians reported they were happy with their work life in 2020, compared with 69% ofthem pre-pandemic

Read More..

Estimating the Impact of COVID-19 on Urology: Data from a Large Nationwide Cohort – DocWire News

This article was originally published here Eur Urol Open Sci.

Read More..

Global Single-Use/Disposable Endoscopy Market Analysis and Forecast, 2021-2030: Significant Increase in Market Size Due to the Ongoing COVID-19…

DUBLIN--(BUSINESS WIRE)--The "Global Single-Use/Disposable Endoscopy Market: Analysis and Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering. The overall market was estimated to be $471.7 million in FY2019, and it is expected to grow at a CAGR of 44.03% during the forecast period, 2021-2030. The global single-use/disposable endoscopy market is witnessing a significant increase in size of the market due to the ongoing COVID-19 pandemic.

Read More..

Theralase Launches Third Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study – BioSpace

TORONTO, ON / ACCESSWIRE / January 25, 2021 / Theralase Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds ("PDC") and their associated drug formulations used to safely and effectively destroy various cancers, bacteria and viruses announced today that MidLantic Urology ("MU") has received site Institutional Review Board ("IRB") approval to commence a Pivotal Phase II Non-Muscle Invasive Bladder Cancer ("NMIBC") Clinical Study to enroll and treat patients with Bacillus Calmette Guerin("BCG")-Unresponsive Carcinoma In-Situ ("CIS") or who are intolerant to BCG Therapy ("Study II"). This marks the third US clinical site that has obtained both study level and site IRB approval through a central IRB.

Read More..

Iowa and Ohio Researchers Discover New, Protective Strategy for Embryonic Development during Prenatal Stress in Animal Model – Newswise

Newswise New research from the University of Iowa and University Hospitals Cleveland Medical Center demonstrates that offspring can be protected from the effects of prenatal stress by administering a neuroprotective compound during pregnancy. Working in a mouse model, Rachel Schroeder, a student in the UI Interdisciplinary Graduate Program in Neuroscience, drew a connection between the work of her two mentors, Hanna Stevens, MD, PhD, UI associate professor of psychiatry and Ida P. Haller Chair of Child and Adolescent Psychiatry, and Andrew A.

Read More..

Andalusia Urology announces new BPH treatment – The Andalusia Star-News – Andalusia Star-News

Andalusia Urology, the office of Robert Long, M.D., today announced it has added a new treatment option, Rezm Water Vapor Therapy a minimally invasive procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms. Rezm Therapy uses natural water vapor to reduce the size of the prostate and provide lasting symptom relief from BPH without invasive surgery or the potential side effects of prescription drugs.1 BPH is a condition in which a mans prostate enlarges and squeezes the urethra, causing frustrating symptoms such as frequent or urgent urination, a weak or interrupted urine stream, and the need to get up several times a night to urinate. It affects about 50% of men by age 60, and 90% of men by age 85.2 For years, the primary options for treating BPH were through behavior modifications, medications or invasive surgery, said Dr

Read More..

Urology Medical Lasers Market Research Report by Laser Type, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19 – Yahoo Finance

Urology Medical Lasers Market Research Report by Laser Type (Diode Laser System, Holmium Laser System, and Thulium Laser System), by Application (Benign Prostatic Hyperplasia (BPH), Non-Muscle-Invasive Bladder Cancer (NMIBC), and Urolithiasis) - Global Forecast to 2025 - Cumulative Impact of COVID-19 New York, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Urology Medical Lasers Market Research Report by Laser Type, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05993425/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

Read More..

Leading Urologist Doubles Down on CaverStem Regenerative Stem Cell Procedure for Treatment of Erectile Dysfunction in Men – BioSpace

PHOENIX, Jan. 20, 2021 /PRNewswire/ --Creative Medical Technology Holdings, Inc.(OTC: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to Urology, Neurology and Orthopedics, today announced that it will be partnering with Dr. Naveen Kella (MD) exclusively in the Austin, TX region to provide CaverStem to patients suffering from Erectile Dysfunction (ED)

Read More..

Published Data Demonstrate Sexual Function Improvement and Preservation with the Minimally Invasive UroLift System Compared to Medications Prescribed…

WAYNE, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that new data published in the peer-reviewed journal, European Urology Focus, found that men treated with the Prostatic Urethral Lift (PUL) procedure (using the UroLift System) showed preservation and some improvement of sexual function compared to men being treated with medication for benign prostatic hyperplasia (BPH).

Read More..

COVID-19 antigen tests at South Bay Hospital – Observer News

Published on: December 31, 2020 SOUTH BAY HOSPITAL PHOTOSLaboratory volunteers from across the West Florida Division of HCA Healthcare administered COVID-19 rapid antigen tests to almost 1,100 area residents Dec. 18 at South Bay Hospital. This was the fifth and final community testing event in 2020 and was provided by the hospital in partnership with Sun City Center C.E.R.T., Sun City Center Emergency Squad, Hillsborough County Sheriffs Office, Hillsborough Community College SouthShore and other local organizations

Read More..

Creative Medical Technology Holdings Announces Patent filing based on Preclinical Data in Model of Heart Attack using ImmCelz Regenerative…

PHOENIX, Dec. 31, 2020 /PRNewswire/ --(OTC CELZ) Creative Medical Technology Holdings Inc. announced today positive preclinical data using ImmCelz in treatment of a model of heart attack

Read More..

Global Breast Biopsy Devices Market to Grow by $ 504.94 Million During 2020-2024 | Featuring Argon Medical Devices Inc., Becton, and Dickinson and Co….

LONDON--(BUSINESS WIRE)--Technavio estimates the global breast biopsy devices market to grow by USD 504.94 million, progressing at a CAGR of about 10% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of breast cancer cases.

Read More..

Top stocks to buy in 2021: Here’s what brokerages say – Business Today

Indian share markets staged a smart recovery in the calendar year 2020 and ended the year at record highs, on the back of positive global news flow and continued foreign fund inflows. On a year-to-date (YTD) basis, broader indices delivered 15% returns, after staging a smart recovery of 84% from the March lows.

Read More..